The use of granulocyte colony stimulating factor to promote wound healing in a neutropenic patient after head and neck surgery.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10091988.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Neutropenia and neutrophil dysfunction, in association with a variety of diseases, has been shown to play a role in poor wound healing. Wound breakdown with fistula formation in patients undergoing total laryngectomy results in significant morbidity and increased hospital stay. Although malnutrition, prior radiation, diabetes, and other diseases are recognized as factors predisposing patients with head and neck cancer to developing fistulas, neutrophil dysfunction should also be considered. Granulocyte colony stimulating factor (G-CSF) has been used successfully to treat neutropenia and neutrophil dysfunction. This study was conducted as a case report. We present the first report of a neutropenic head and neck cancer patient with a persistent wound of 6 months' duration who showed dramatic improvement after treatment with G-CSF. We conclude that G-CSF may represent a useful adjunct in patients with persistent wound healing problems and neutropenia despite adequate treatment by conventional means. Further clinical experience with G-CSF in patients with delayed healing is indicated.
Medical subject headings
- Cutaneous Fistula
- Fistula
- Granulocyte Colony-Stimulating Factor
- Laryngectomy
- Neutropenia
- Pharyngeal Diseases
- Wound Healing